title: Effective treatment of idiopathic chronic cold urticaria with omalizumab: report of 3 cases.
authors.forename: Amandine
authors.initials: A
authors.lastname: Le Moing
authors.forename: Céline
authors.initials: C
authors.lastname: Bécourt
authors.forename: Emeline
authors.initials: E
authors.lastname: Pape
authors.forename: Yves
authors.initials: Y
authors.lastname: Dejobert
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Delaporte
authors.forename: Delphine
authors.initials: D
authors.lastname: Staumont-Sallé
mesh_terms: D000328:Adult; D000368:Aged; D000888:Antibodies, Anti-Idiotypic / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D003080:Cold Temperature / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007279:Injections, Subcutaneous; D000069444:Omalizumab; D012008:Recurrence; D018570:Risk Assessment; D012494:Sampling Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014581:Urticaria / Q000188:drug therapy* / Q000209:etiology; D055815:Young Adult
chemical_list: D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab